- Case Report
- Open access
- Published:
Peritoneal dialysis-associated polymicrobial peritonitis with slow onset after root canal treatment: the first case and review of the literature
BMC Nephrology volume 26, Article number: 137 (2025)
Abstract
Background
Peritoneal dialysis (PD)-associated peritonitis is linked to an increased risk of mortality and catheter removal, with a higher incidence of these risks observed in polymicrobial peritonitis compared with single-organism infection. In PD patients, invasive procedures can cause peritonitis, typically within 7 days, through transient bacteremia. Although dental procedures are widely recognized as a cause of transient bacteremia, only a limited number of cases involving PD-associated peritonitis after dental procedures, and no cases of polymicrobial peritonitis, have been reported.
Case presentation
A 60-year-old man undergoing PD presented with acute low abdominal pain, and was diagnosed with PD-associated peritonitis caused by Streptococcus (S.) oralis, S. vestibularis, and S. salivarius. The polymicrobial peritonitis was successfully treated with antibiotics and catheter removal was not required. Medical consultation after admission revealed a history of root canal treatment for dental caries in the right maxillary second molar, and a dental examination during hospitalization confirmed its success.
Conclusions
We report a case of PD-associated peritonitis caused by co-infection with three species of viridans group streptococci, which developed 9 days after the completion of root canal treatment. This case history suggests that it may be important to carefully observe patients until 10 days after dental procedures, because of the slow onset of peritonitis following such procedures.
Background
Peritoneal dialysis (PD)-associated peritonitis, a common and serious complication of PD, is associated with a higher risk of mortality [1,2,3]. It frequently leads to a reduction in peritoneal ultrafiltration capacity, and is the most common cause of permanent hemodialysis transfer [4]. Polymicrobial infection occurs in 16% of patients with PD-associated peritonitis, accounting for 6–8% of peritonitis episodes [5, 6]. Catheter removal is required in 22–33% of polymicrobial infections, resulting in transfer to hemodialysis [5, 6]. Thus, although polymicrobial peritonitis is relatively uncommon, the risk of catheter removal is higher compared with single-organism infection [6].
The end-stage kidney disease (ESKD) population has severe oral disease compared with the general population [7]. Oral diseases represent a potential but preventable cause of poor health outcomes in people with ESKD because of their relationship to infection, inflammation, and malnutrition. A recent large multicenter study revealed that poor oral hygiene was present in a quarter of PD patients and was independently associated with a higher risk of peritonitis and death [8]. Furthermore, dental or oral procedures are widely recognized as a cause of transient bacteremia. In PD patients, transient bacteremia after invasive procedures can lead to peritonitis, usually within 7 days [9,10,11,12,13]. To date, a limited number of cases involving PD-associated peritonitis after dental procedures have been reported [14, 15]; however, none of these cases has developed peritonitis after root canal treatment, a known cause of transient bacteremia [16].
Approximately 5–10% of all PD-associated peritonitis cases are caused by Streptococcus species, which are the most frequently isolated organisms from odontogenic bacteremic patients after dental procedures [9, 17]. Streptococcus (S.) viridans is the predominant organism observed in PD patients with post-dental procedure peritonitis [9, 15] because viridans group streptococci (VGS) normally reside in the oral cavity. Although some cases exhibited polymicrobial peritonitis with S. viridans, no cases have been reported after oral or dental procedures. We report a case of PD-associated peritonitis caused by co-infection with three species of VGS, S. oralis, S. vestibularis, and S. salivarius, 9 days after the completion of root canal treatment. This polymicrobial peritonitis was successfully treated with antibiotics.
Case presentation
A 60-year-old Japanese man with ESKD caused by autosomal dominant polycystic kidney disease had been undergoing PD for 1 year, and was admitted to our hospital with acute low abdominal pain. He was being treated with continuous cycling PD: automated PD during the night using 1.5% glucose solution (Reguneal LCa 1.5%; Baxter, Tokyo, Japan) and daytime use of 7.5% icodextrin solution (Extraneal; Baxter). He used an ultraviolet light-based tubing welder (Tsunagu; Baxter) to connect and disconnect dialysate bags. His medical history included hypertension, dyslipidemia, and ischemic heart disease, but not diabetes mellitus. He was regularly taking diltiazem, alfacalcidol, sacubitril valsartan, vonoprazan, atorvastatin, furosemide, torsemide, and tolvaptan. One year before presentation, he had PD-associated peritonitis caused by Enterobacter cloacae, which was successfully treated with antibiotics. His daily living activities were unremarkable, and he did not smoke or regularly consume alcohol.
On admission, his blood pressure was 102/64 mmHg, respiratory rate 12 per minute, heart rate 76 per minute, temperature 36.3 °C, and oxygen saturation 98% on ambient air. His height was 170 cm, weight 60.8 kg, and body mass index 21. The physical examination revealed abdominal distension and tenderness throughout, with no apparent muscular defense or recoil pain. There were no findings suggestive of an exit site or tunnel infection. Laboratory findings are shown in Table 1. His white blood cell count was 5,690/µL, and serum C-reactive protein (CRP) concentration was 0.05 mg/dL. The PD effluent was cloudy, and the white cell count was elevated at 7,500/µL (neutrophils, 93.2%), resulting in a diagnosis of PD-associated peritonitis. Because the previous peritonitis caused by Enterobacter cloacae was resistant to third-generation cephalosporins, intravenous administration of cefepime was started. The patient’s white blood cell count (9,170/µL) and CRP level (23.03 mg/dL) were elevated on treatment day 2, but decreased to 6,000/µL and 5.20 mg/dL on treatment day 6, respectively (Fig. 1). Similarly, the white cell count in the PD effluent was elevated at 9,750/µL on treatment day 2, but decreased to 230/µL on treatment day 6 (Fig. 1). Contrast-enhanced computed tomography of the abdomen did not reveal any abscesses in the abdominal cavity or around the PD catheter. Transthoracic echocardiography revealed no vegetation or valvular regurgitation.
S. oralis and S. salivarius were detected on treatment day 1, and S. vestibularis was detected on treatment day 5 in the PD effluent culture. Two sets of blood cultures obtained before starting the antibiotic therapy tested negative. To elucidate the infection route, the patient was asked about his dental history. He revealed that 2 weeks before the hospitalization, he had visited a dentist because of toothache in the right maxillary second molar; root canal treatment had been initiated and was completed 9 days before admission. No prophylactic antibiotics had been administered. A dental examination during hospitalization confirmed the oral cavity was clean, with no observed dental caries and the success of the root canal treatment. Because the three Streptococcus species are susceptible to a wide range of antibiotics (Table 2), cefepime was de-escalated to ceftriaxone on day 8 (Fig. 1). The white cell count in the PD effluent decreased to less than 100 µL on day 8, and did not worsen thereafter (Fig. 1). In line with the recommendations of the 2022 International Society for Peritoneal Dialysis (ISPD) guidelines [18], the patient was treated with antibiotics for a total of 2 weeks. No deterioration in the clinical findings was observed, and he was discharged on day 16.
Discussion and conclusions
Viridans group streptococci are divided into five different groups: mutans, anginosus, mitis, sanguinis, and salivarius [19]. S. oralis, a virulent member of the mitis group, is known to be a common pathogen of endocarditis, while S. salivarius and S. vestibularis, members of salvarius group, are less common but can be isolated in patients with endocarditis [20,21,22]. To date, eleven cases of PD-associated peritonitis caused by mono-infection of S. oralis, S. salvarius, or S. vestibularis have been reported (Table 3), and among them, only one case was peritonitis following a dental procedure [14, 23,24,25,26,27,28,29,30,31]. Therefore, this is the first reported case of PD-associated polymicrobial peritonitis caused by co-infection with S. oralis, S. salivarius, and S. vestibularis.
Although touch contamination is the main cause of PD-associated peritonitis due to VGS [32], other sources, including oral, respiratory, and gastrointestinal routes, should also be considered, especially in patients with dental disease or recent procedures [11, 27]. In this case, the patient developed peritonitis after the completion of root canal treatment for dental caries, and dental examination confirmed its success. While two sets of blood cultures were negative, bacteria that enter the bloodstream during dental procedures are known to be rapidly cleared within 15Â min [33], leaving the possibility that transient bacteremia following root canal therapy may have caused the PD-associated peritonitis. This possibility is supported by the isolation of S. salivarius from the PD effluent culture because this microorganism is rarely responsible for any infections in adults except dental caries [19]. In this case, during PD exchanges, the patient had used not only a mask, gloves, but also an ultraviolet light-based PD catheter connection system, which produces a germicidal effect [34] and significantly decreases the incidence of peritonitis [35]. This is consistent with a recent report showing that PD-associated peritonitis caused by S. oralis developed after a tooth extraction [14]. Although the possibility of contamination by saliva droplets cannot be completely excluded, we hypothesize that, in our case, transient bacteremia occurred following root canal therapy, leading to PD-associated polymicrobial peritonitis with three species of VGS.
Our patient developed PD-associated peritonitis 9 days after the final dental procedure. In previous cases of PD-associated peritonitis, no cases occurred within 1 day of a dental procedure (Fig. 2) [14, 15]. In contrast, PD-associated peritonitis often occurs within 1 day of colonoscopy (Fig. 2) [12, 13, 36,37,38,39,40,41,42,43]. Thus, the onset of peritonitis after dental procedures is slower than that after colonoscopy (Fig. 2). The present case can be considered to be unique in that the onset was slower than that of other cases of peritonitis caused by dental procedures. Although one case reported the development of peritonitis 4 weeks after a tooth extraction, prophylactic antibiotic treatment had been administered from 2 days before the procedure. Additionally, wound healing was delayed until the peritonitis developed [14]; thus, delayed wound healing might be a more reasonable explanation for the development of peritonitis than the tooth extraction itself. Similarly, we speculate that transient bacteremia occurred during the wound healing process in this case, although dental procedures had been completed at the dental examination. Colonoscopy-related peritonitis is defined as peritonitis developing within 1 day or 1 week of colonoscopy [44,45,46]. Therefore, it is important to carefully observe PD patients for up to 10 days after dental procedures, even if the wound is healing well. Furthermore, although the onset of dental procedure-related peritonitis is slow, if peritonitis occurs more than 10 days after the dental procedure, other reasons for the infection should be investigated.
Late onset of peritonitis after dental procedures. The data of time to peritonitis were obtained from the previous reports showing PD-associated peritonitis after colonoscopy [12, 13, 36,37,38,39,40,41,42,43] or dental procedures [14, 15]. Comparison was analyzed using the two-tailed t test. Cases of polymicrobial peritonitis were plotted as closed tri-angels. Cases of peritonitis with single-organism or culture-negative were plotted as closed circles. This case is indicated by red closed tri-angle
Prophylactic antibiotic treatment was not administered in our case, although root canal therapy is a known cause of transient bacteremia [16]. One possible reason is that the exact frequency of peritonitis associated with the transient bacteremia from dental procedures and the efficacy of antibiotic prophylaxis to prevent peritonitis have not yet been definitively established. This contrasts with the increasing evidence supporting antibiotic prophylaxis in PD patients undergoing colonoscopy [12, 18, 44]. Indeed, the 2022 ISPD guidelines state only that clinical trials are required to assess the benefits and harms of antibiotic prophylaxis before dental procedures [18]. Similarly, the American Dental Association currently lacks specific guidelines for antibiotic prophylaxis in PD patients, as discussed in a previous review [47]. Transient bacteremia after dental procedures is common and antibiotic prophylaxis has been shown to reduce its frequency [48], thereby decreasing persistent bacteremia and endocarditis, especially in patients at high risk [49]. In PD patients, transient bacteremia following dental disease or recent procedures can lead to PD-associated peritonitis even without persistent bacteremia [11, 27], highlighting the importance of reducing its occurrence through antibiotic prophylaxis, as PD patients are at high risk of peritonitis. Therefore, it seems reasonable for PD patients to be given antibiotic prophylaxis before undergoing dental surgery, as stated in the 2016 ISPD guidelines [50]. Only 6 cases of PD-associated peritonitis have been associated with dental or oral procedures, including our case [9, 14]. Hence, further case reports and clinical studies are required to evaluate the precise frequency and the efficacy of antibiotic prophylaxis prior to dental procedures in PD patients.
In our patient, polymicrobial peritonitis was clearly improved by antibiotics, and catheter removal was not required. Similarly, there have been no reported cases of catheter removal and relapse/recurrence in patients with PD-associated peritonitis caused by S. orlais, S. salivarius, or S. vestibularis (Table 3) [14, 23,24,25,26,27,28,29,30,31]. This is consistent with a previous paper showing a low risk of catheter loss (2.6%) in patients with single-organism VGS group infection [51]. Although catheter loss overall was higher in the polymicrobial peritonitis group with VGS (16.1%) [51], this finding is similar to another study demonstrating that 17% of patients with polymicrobial peritonitis with pure gram-positive organisms required catheter removal [52]. Therefore, it is crucial to closely monitor patients with polymicrobial peritonitis compared with those with single-organism VGS, although pure gram-positive polymicrobial peritonitis has less impact on catheter removal than other types of polymicrobial peritonitis, including mixed gram-negative and gram-positive, pure gram-negative, or mixed bacterial and fungal organisms [52].
In conclusion, we report a case of PD-associated polymicrobial peritonitis with S. oralis, S. salivarius, and S. vestibularis, which may have been caused by transient bacteremia after a dental procedure. Because the onset of peritonitis after dental procedures is slower than that after colonoscopy, it is important to carefully observe the patient until 10 days after the dental procedure. This case supports the need for further studies evaluating the use of prophylactic antibiotics prior to dental procedures in PD patients.
Data availability
Data is provided within the manuscript.
Abbreviations
- CRP:
-
C-reactive protein
- ESKD:
-
End stage kidney disease
- PD:
-
Peritoneal dialysis
- S.:
-
Streptococcus
- UV:
-
Ultraviolet
- VGS:
-
Viridans group streptococci
References
Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996;7(10):2176–82.
Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, McDonald SP, Wiggins KJ, Bannister KM, Brown FG, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–405.
Ye H, Zhou Q, Fan L, Guo Q, Mao H, Huang F, Yu X, Yang X. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrol. 2017;18(1):186.
Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, et al. Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal Dialysis. Clin J Am Soc Nephrol. 2017;12(7):1090–9.
Kiernan L, Finkelstein FO, Kliger AS, Gorban-Brennan N, Juergensen P, Mooraki A, Brown E. Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1995;25(3):461–4.
Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 2000;36(5):1000–8.
Costantinides F, Castronovo G, Vettori E, Frattini C, Artero ML, Bevilacqua L, Berton F, Nicolin V, Di Lenarda R. Dental care for patients with End-Stage renal disease and undergoing Hemodialysis. Int J Dent. 2018;2018:9610892.
Purisinsith S, Kanjanabuch P, Phannajit J, Kanjanabuch T, Puapatanakul P, Johnson DW, Pongpirul K, Perl J, Robinson B, Tungsanga K, et al. Oral Health-Related quality of life, A proxy of poor outcomes in patients on peritoneal Dialysis. Kidney Int Rep. 2022;7(10):2207–18.
Shukla A, Abreu Z, Bargman JM. Streptococcal PD peritonitis–a 10-year review of one centre’s experience. Nephrol Dial Transpl. 2006;21(12):3545–9.
Levy M, Balfe JW, Geary D, Fryer-Keene SP. Factors predisposing and contributing to peritonitis during chronic peritoneal dialysis in children: a ten-year experience. Perit Dial Int. 1990;10(4):263–9.
Machuca E, Ortiz AM, Rabagliati R. Streptococcus viridans-associated peritonitis after gastroscopy. Adv Perit Dial. 2005;21:60–2.
Yip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int. 2007;27(5):560–4.
Poortvliet W, Selten HP, Raasveld MH, Klemt-Kropp M. CAPD peritonitis after colonoscopy: follow the guidelines. Neth J Med. 2010;68(9):377–8.
Mihara Y, Kado H, Matsumoto K, Kurose R, Tsujinaka E, Nakai K, Yamauchi A, Hatta T. Peritoneal Dialysis-associated peritonitis due to Streptococcus oralis three weeks after peritoneal Dialysis initiation: A case report. Intern Med 2023.
Kiddy K, Brown PP, Michael J, Adu D. Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed). 1985;290(6473):969–70.
Debelian GJ, Olsen I, Tronstad L. Bacteremia in conjunction with endodontic therapy. Endod Dent Traumatol. 1995;11(3):142–9.
O’Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol. 2009;10:19.
Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–53.
Ahmed N, Tariq P, Naim A. Viridans group Streptococci and dental caries: an overview. Int J Biol Biotech. 2023;20(1):3–16.
Douglas CW, Heath J, Hampton KK, Preston FE. Identity of viridans Streptococci isolated from cases of infective endocarditis. J Med Microbiol. 1993;39(3):179–82.
Partridge SM. Prosthetic valve endocarditis due to Streptococcus vestibularis. J Infect. 2000;41(3):284–5.
Hoecker JL, Pickering LK, Groschel D, Kohl S. Streptococcus salivarius sepsis in children with malignancies. J Pediatr. 1978;92(2):337–8.
Chaker H, Brahim RB, Toumi S, Kammoun K, Mseddi F, Yaich S, Hmida MB. Unusual cause of peritonitis in peritoneal Dialysis patient related to Streptococcus salivarius. Saudi J Kidney Dis Transpl. 2021;32(3):838–40.
Barajas-Colon E, Warady BA. Streptococcus salivarius peritonitis in an infant receiving chronic peritoneal dialysis. Perit Dial Int. 2021;41(3):341–3.
Koruk ST, Hatipoglu CA, Oral B, Yucel M, Demiroz AP. Streptococcus oralis: a rare cause of CAPD-related peritonitis. Perit Dial Int. 2005;25(3):290–1.
Amirou M, Lombart D, Thomas K, Watine J. [Recurring peritonitis due to Streptococcus from the upper respiratory tract in a saxophone player under peritoneal dialysis]. Ann Biol Clin (Paris). 2012;70(2):207–9.
Kotani A, Oda Y, Hirakawa Y, Nakamura M, Hamasaki Y, Nangaku M. Peritoneal Dialysis-Related peritonitis caused by Streptococcus oralis. Intern Med. 2021;60(21):3447–52.
Kasikci E, Tas MY, Ceri M, Dursun B. Unusual cause of peritonitis in peritoneal dialysis: Streptococcus vestibularis. Ther Apher Dial. 2018;22(4):412–3.
Yilmaz F, Bora F, Ersoy F. Streptococcus vestibularis: A rare cause of peritoneal Dialysis-Related peritonitis. Ther Apher Dial. 2017;21(4):418–9.
Mert M, Ceri M, Dursun B. Peritoneal Dialysis-Related peritonitis with Streptococcus mitis. Saudi J Kidney Dis Transpl. 2021;32(4):1180–1.
Mizuno M, Ito Y, Masuda T, Toda S, Hiramatsu H, Suzuki Y, Ozaki T, Yasuda Y, Ito I, Tsuboi N, et al. A case of fulminant peritonitis caused by Streptococcus mitis in a patient on peritoneal dialysis. Intern Med. 2011;50(5):471–4.
Chao CT, Lee SY, Yang WS, Chen HW, Fang CC, Yen CJ, Chiang CK, Hung KY, Huang JW. Viridans Streptococci in peritoneal dialysis peritonitis: clinical courses and long-term outcomes. Perit Dial Int. 2015;35(3):333–41.
Mang-de la Rosa MR, Castellanos-Cosano L, Romero-Perez MJ, Cutando A. The bacteremia of dental origin and its implications in the appearance of bacterial endocarditis. Med Oral Patol Oral Cir Bucal. 2014;19(1):e67–74.
Ashley J, Rasooly JA, Tran I, Yost LE, Chertow GM. Effect of UV light on disinfection of peritoneal Dialysis catheter connections. Perit Dial Int. 2017;37(1):109–11.
Stegmayr BG, Granbom L, Tranaeus A, Wikdahl AM. Reduced risk for peritonitis in CAPD with the use of a UV connector box. Perit Dial Int. 1991;11(2):128–30.
Ray SM, Piraino B, Holley J. Peritonitis following colonoscopy in a peritoneal dialysis patient. Perit Dial Int. 1990;10(1):97–8.
Petersen JH, Weesner RE, Giannella RA. Escherichia coli peritonitis after left-sided colonoscopy in a patient on continuous ambulatory peritoneal dialysis. Am J Gastroenterol. 1987;82(2):171–2.
Verger C, Danne O, Vuillemin F. Colonoscopy and continuous ambulatory peritoneal dialysis. Gastrointest Endosc. 1987;33(4):334–5.
Bac DJ, van Blankenstein M, de Marie S, Fieren MW. Peritonitis following endoscopic polypectomy in a peritoneal dialysis patient: the need for antibiotic prophylaxis. Infection. 1994;22(3):220–1.
Lin YC, Lin WP, Huang JY, Lee SY. Polymicrobial peritonitis following colonoscopic polypectomy in a peritoneal dialysis patient. Intern Med. 2012;51(14):1841–3.
Wu HH, Li IJ, Weng CH, Lee CC, Chen YC, Chang MY, Fang JT, Hung CC, Yang CW, Tian YC. Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLoS ONE. 2013;8(8):e71532.
Gayen S, Ziemba Y, Jaiswal S, Frank A, Brahmbhatt Y. CDC group EO-4 and Candida tropicalis peritonitis in a patient on peritoneal Dialysis after upper endoscopy, colonoscopy and coil embolization of the gastroduodenal artery. Case Rep Gastroenterol. 2016;10(3):728–32.
Zhuang ZF, Ye ZH, Zhong ZS, He GH, Wang J, Huang SP. A case report of a post-polypectomy syndrome with severe sepsis and organ dysfunction. Ann Palliat Med. 2020;9(2):488–92.
Gweon TG, Jung SH, Kim SW, Lee KM, Cheung DY, Lee BI, Choi H. Risk factors for peritonitis in patients on continuous ambulatory peritoneal dialysis who undergo colonoscopy: a retrospective multicentre study. BMC Gastroenterol. 2019;19(1):175.
Cha RR, Kim HJ, Lee CM, Lee JM, Lee SS, Cho HJ, Ha CY, Kim HJ, Lee OJ. Clinical characteristics and outcome of iatrogenic colonic perforation related to diagnostic vs. therapeutic colonoscopy. Surg Endosc. 2022;36(8):5938–46.
Au CWH, Chan CK, Wong CK, Ho EHS, Chow VCC, Mo SKL. Clinical characteristics and outcomes of peritoneal dialysis (PD)-related peritonitis after colonoscopy. Perit Dial Int 2023:8968608231172744.
Hsueh L, Hu SL, Shah AD. Periprocedural peritonitis prophylaxis: A summary of the microbiology and the role of systemic antimicrobials. Kidney Dis (Basel). 2021;7(2):90–9.
Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25.
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, et al. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, Council on cardiovascular disease in the young, and the Council on clinical cardiology, Council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116(15):1736–54.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
Liu Y, Cheng BC, Liu JW, Chen CJ, Kuo LC, Chang WX, Chen JB. Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent polymicrobial infection. BMC Nephrol. 2018;19(1):271.
Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis. 2010;55(1):121–31.
Acknowledgements
We thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.
Funding
YM is funded by the Japan Society for the Promotion of Science KAKENHI (grant number 23K19566) and the Tsuchiya Foundation.
Author information
Authors and Affiliations
Contributions
S.K., Y.M., K.O., R.Y., and A.T. treated the patient. S.K. and Y.M. drafted the manuscript. S.K., Y.M., A.T., M.Y., N.I., Y.O., K.S. and T.M. revised the manuscript critically. All authors read and approved the final manuscripts.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study was conducted according to the guidelines laid down in the Declaration of Helsinki. Informed consent was obtained from the patient described in this case report, and the consent allowed their data to be stored, as required by the Hiroshima University Hospital.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kubota, S., Maeoka, Y., Okimoto, K. et al. Peritoneal dialysis-associated polymicrobial peritonitis with slow onset after root canal treatment: the first case and review of the literature. BMC Nephrol 26, 137 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12882-025-04054-x
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12882-025-04054-x